BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-08656795 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-08656795\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07876518-11276@assetmemo.bio
DTSTAMP:20261121T005603Z
DTSTART;VALUE=DATE:20281116
DTEND;VALUE=DATE:20281117
SUMMARY:PF-08656795: Phase 1 readout est. (NCT07876518)
DESCRIPTION:PF-08656795\, phase 1\, Obesity.\nStudy: A Study to Learn How D
 ifferent Amounts of the Study Medicine Called PF-08656795 Are Tolerated an
 d Act in Adults With Overweight or Obesity\nEstimated primary completion: 
 16 November 2028. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/pf-
 08656795#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07876518
URL:https://assetmemo.bio/drug/pf-08656795#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
